|
Aug 11
|
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates
|
|
Aug 11
|
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot
|
|
Aug 11
|
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025
|
|
Jul 25
|
One Enanta Pharmaceuticals Insider Raised Their Stake In The Previous Year
|
|
Jul 15
|
Enanta Pharmaceuticals to Participate in Baird’s Biotech Discovery Series
|
|
Feb 15
|
With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns
|
|
Feb 15
|
President of Enanta Pharmaceuticals Picks Up 5.9% More Stock
|
|
Feb 14
|
Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade
|
|
Feb 10
|
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
|
|
Feb 10
|
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
|
|
Feb 10
|
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024
|